The Latest Headlines at American Banking and Market News
Matt Abernethy Sells 15,000 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) CFO Matt Abernethy sold 15,000 shares of the stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $140.24, for a total value... More of this article »
Barrington Research Weighs in on AMC Entertainment Holdings, Inc.’s Q1 2025 Earnings (NYSE:AMC)
AMC Entertainment Holdings, Inc. (NYSE:AMC – Free Report) – Barrington Research issued their Q1 2025 earnings estimates for shares of AMC Entertainment in a research note issued on Tuesday, May 14th. Barrington Research... More of this article »
Roth Capital Comments on Ayr Wellness Inc.’s Q1 2025 Earnings (OTCMKTS:AYRWF)
Ayr Wellness Inc. (OTCMKTS:AYRWF – Free Report) – Equities researchers at Roth Capital issued their Q1 2025 earnings per share estimates for shares of Ayr Wellness in a research report issued on Wednesday, May 15th.... More of this article »
Blueprint Medicines Co. (NASDAQ:BPMC) Short Interest Up 6.8% in April
Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) was the target of a large growth in short interest in April. As of April 30th, there was short interest totalling 4,540,000 shares, a growth of 6.8% from the April 15th... More of this article »
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Short Interest Up 6.0% in April
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 3,910,000 shares, a growth of... More of this article »
Frank Hurst Lin Sells 92,886 Shares of GigaCloud Technology Inc. (NASDAQ:GCT) Stock
GigaCloud Technology Inc. (NASDAQ:GCT – Get Free Report) Director Frank Hurst Lin sold 92,886 shares of the firm’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $36.78, for... More of this article »
Brokers Offer Predictions for Allogene Therapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:ALLO)
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – HC Wainwright issued their Q1 2025 earnings per share estimates for Allogene Therapeutics in a report released on Thursday, May 16th. HC Wainwright analyst R.... More of this article »
Q1 2025 EPS Estimates for Chubb Limited (NYSE:CB) Raised by Zacks Research
Chubb Limited (NYSE:CB – Free Report) – Zacks Research increased their Q1 2025 earnings per share (EPS) estimates for Chubb in a research report issued to clients and investors on Thursday, May 16th. Zacks Research... More of this article »
Q1 2025 EPS Estimates for Capital Southwest Co. (NASDAQ:CSWC) Boosted by Analyst
Capital Southwest Co. (NASDAQ:CSWC – Free Report) – Equities research analysts at B. Riley raised their Q1 2025 earnings per share estimates for Capital Southwest in a report released on Thursday, May 16th. B. Riley... More of this article »
Riskified (NYSE:RSKD) PT Raised to $7.00 at DA Davidson
Riskified (NYSE:RSKD – Get Free Report) had its price objective boosted by DA Davidson from $5.00 to $7.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on... More of this article »
Manhattan Associates (NASDAQ:MANH) PT Raised to $260.00 at DA Davidson
Manhattan Associates (NASDAQ:MANH – Get Free Report) had its target price upped by research analysts at DA Davidson from $240.00 to $260.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently... More of this article »
monday.com (NASDAQ:MNDY) PT Raised to $230.00 at DA Davidson
monday.com (NASDAQ:MNDY – Get Free Report) had its price objective lifted by analysts at DA Davidson from $190.00 to $230.00 in a report issued on Thursday, Benzinga reports. The firm presently has a “neutral” rating... More of this article »
DA Davidson Lowers Wag! Group (NASDAQ:PET) Price Target to $3.50
Wag! Group (NASDAQ:PET – Get Free Report) had its price objective lowered by research analysts at DA Davidson from $6.00 to $3.50 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage... More of this article »